PROKIDNEY CORP. (PROK)
2025-06-30 | 2025-03-31 | |||
|---|---|---|---|---|
| Revenue | 221 | - | ||
| Research and development | 25,882 | - | ||
| General and administrative | 14,048 | - | ||
| Total operating expenses | 39,930 | - | ||
| Operating loss | -39,709 | - | ||
| Interest income | 3,593 | 4,027 | ||
| Interest expense | 1 | - | ||
| Net loss before income taxes | -36,117 | - | ||
| Income tax expense (benefit) | 848 | - | ||
| Net loss before noncontrolling interest | -36,965 | - | ||
| Basic eps | - | -0.13 | ||
| Diluted eps | - | -0.13 | ||
| Basic average shares | - | 128,976,366 | ||
| Diluted average shares | - | 128,976,366 | ||